title: Response to Interleukin (IL)-17 Inhibition in an Adolescent With Severe Manifestations of IL-36 Receptor Antagonist Deficiency (DITRA).
authors.affiliation: Department of Dermatology, University of California-San Francisco School of Medicine, San Francisco.
authors.forename: Kelly M
authors.initials: KM
authors.lastname: Cordoro
authors.affiliation: Department of Dermatology, University of California-San Francisco School of Medicine, San Francisco.
authors.forename: Derya
authors.initials: D
authors.lastname: Ucmak
authors.affiliation: Department of Dermatology, University of California-San Francisco School of Medicine, San Francisco.
authors.forename: Maria
authors.initials: M
authors.lastname: Hitraya-Low
authors.affiliation: Department of Dermatology, University of California-San Francisco School of Medicine, San Francisco.
authors.forename: Michael D
authors.initials: MD
authors.lastname: Rosenblum
authors.affiliation: Department of Dermatology, University of California-San Francisco School of Medicine, San Francisco.
authors.forename: Wilson
authors.initials: W
authors.lastname: Liao
mesh_terms: D000293:Adolescent; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D001706:Biopsy; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D007279:Injections, Subcutaneous; D053590:Interleukin 1 Receptor Antagonist Protein / Q000172:deficiency*; D020381:Interleukin-17 / Q000037:antagonists & inhibitors*; D007378:Interleukins / Q000235:genetics / Q000378:metabolism; D008297:Male; D009154:Mutation; D011565:Psoriasis / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D012867:Skin / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C508717:IL17A protein, human; C122187:IL36RN protein, human; D053590:Interleukin 1 Receptor Antagonist Protein; D020381:Interleukin-17; D007378:Interleukins; C555450:secukinumab